Abstract
Background: Adolescents/young adults (AYA) with chronic kidney disease (CKD) or end-stage kidney disease (ESKD) are at risk for poor health outcomes related to self-management. To improve their health and quality of life, AYA must build self-management (for those in the pediatric- and adult-focused setting) and/or health care transition (HCT) skills (for those in the pediatric setting). Methods: Self-management and/or HCT encompass a variety of domains that must be tailored to each individual. Annual assessments should begin between the ages of 12 and 14 and continue in the adult-focused setting until patients have achieved demonstrated self-management and/or HCT skills mastery. These assessments will guide interventions that are congruent in terms of literacy, development and culture. Facilitation of this process from the perspective of both the pediatric and the adult health-care systems is described. Conclusions: Deficiencies and barriers to self-management and/or HCT for AYA with ESKD remain. There is no consensus on the definition of successful HCT preparation, with few tools to assess transition readiness and/or self-management. It is important for health providers to promote the self-management and/or health-care transition skills of AYA with ESKD. Customization of these activities and involvement of the whole family will contribute towards better health-related quality of life and patient outcomes.
References
1.
Ferris ME, Gipson DS, Kimmel PL, Eggers PW: Trends in treatment and outcomes of survival of adolescents initiating ESRD care in the United States. Pediatr Nephrol 2006;21:1020-1026.
2.
Andreoni KA, Forbes R, Andreoni RM, Phillips G, Stewart H, Ferris M: Age-related kidney transplant outcomes: health disparities amplified in adolescence. JAMA Intern Med 2013;173:1524-1532.
3.
Koshy SM, Hebert D, Lam K, Stukel TA, Guttmann A: Renal allograft loss during transition to adult healthcare services among pediatric renal transplant patients. Transplantation 2009;87:1733-1736.
4.
USRDS: http://www.usrds.org/reference.aspx (last visited August 20, 2014).
5.
Usvyat LA, Haviv YS, Etter M, Kooman J, Marcelli D, Marelli C, et al: The MONitoring Dialysis Outcomes (MONDO) initiative. Blood Purif 2013;35:37-48.
6.
Ferris ME, Mahan JD: Pediatric chronic kidney disease and the process of health care transition. Semin Nephrol 2009;29:435-444.
7.
Gipson DS, Hooper SR, Duquette PJ, Wetherington CE, Stellwagen KK, Jenkins TL, et al: Memory and executive functions in pediatric chronic kidney disease. Child Neuropsychol 2006;12:391-405.
8.
Groothoff JW, Grootenhuis MA, Offringa M, Stronks K, Hutten GJ, Heymans HS: Social consequences in adult life of end-stage renal disease in childhood. J Pediatr 2005;146:512-517.
9.
Bartosh SM, Leverson G, Robillard D, Sollinger HW: Long-term outcomes in pediatric renal transplant recipients who survive into adulthood. Transplantation 2003;76:1195-1200.
10.
So TY, Layton JB, Bozik K, Farrington E, Gipson PE, Gibson K, Primack W, et al: Cognitive pharmacy services at a pediatric nephrology and hypertension clinic. Ren Fail 2011;33:19-25.
11.
Curtin RB, Walters BA, Schatell D, Pennell P, Wise M, Klicko K: Self-efficacy and self-management behaviors in patients with chronic kidney disease. Adv Chronic Kidney Dis 2008;15:191-205.
12.
Kutner NG, Zhang R, McClellan WM, Cole SA: Psychosocial predictors of non-compliance in haemodialysis and peritoneal dialysis patients. Nephrol Dial Transplant 2002;17:93-99.
13.
Andreoni A, Forbes R, Andreoni RM, Phillips G, Stewart H, Ferris M: Age-related kidney transplant outcomes: health disparities amplified in adolescence. JAMA Intern Med 2013;173:1524-1532.
14.
Watson AR, Harden P, Ferris M, Kerr PG, Mahan J, Ramzy MF: Transition from pediatric to adult renal services: a consensus statement by the International Society of Nephrology (ISN) and the International Pediatric Nephrology Association (IPNA). Pediatr Nephrol 2011;26:1753-1757.
15.
Brennan P, Safran C: Report of conference track 3: patient empowerment. Int J Med Inform 2003;69:301-304.
16.
Curtin RB, Sitter DC, Schatell D, Chewning BA: Self-management, knowledge, and functioning and well-being of patients on hemodialysis. Nephrol Nurs J 2004;31:378-386.
17.
Curtin RB, Mapes D, Schatell D, Burrows-Hudson S: Self-management in patients with end stage renal disease: exploring domains and dimensions. Nephrol Nurs J 2005;32:389-395.
18.
Ong SW, Jassal SV, Porter E, Logan AG, Miller JA: Using an electronic self-management tool to support patients with chronic kidney disease (CKD): a CKD clinic self-care model. Semin Dial 2013;26:195-202.
19.
Ferris ME, et al: A clinical tool to measure the components of health-care transition from pediatric care to adult care: the UNC TR(x)ANSITION scale. Ren Fail 2012;34:744-753.
20.
Sevick MA, Trauth JM, Ling BS, Anderson RT, Piatt GA, Kilbourne AM, et al: Patients with Complex Chronic Diseases: perspectives on supporting self-management. J Gen Intern Med 2007;22:438-444.
21.
Blum RW, et al: Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. J Adolesc Health 1993;14:570-576.
22.
Betz CL, et al: The health care transition research consortium health care transition model: a framework for research and practice. J Pediatr Rehabil Med 2014;7:3-15.
23.
U.S. Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau: The National Survey of Children with Special Health Care Needs Chartbook 2009-2010. Rockville, Maryland, U.S. Department of Health and Human Services, 2013.
24.
Cooley WC, Sagerman PJ; American Academy of Pediatrics; American Academy of Family Physicians; American College of Physicians; Transitions Clinical Report Authoring Group: Supporting the health care transition from adolescence to adulthood in the medical home. Pediatrics 2011;128:182-200.
25.
The National Health Care Transition Centers ‘Got Transition': http://www.gottransition.org/ (accessed August 29).
26.
Bell LE, Ferris ME, Fenton N, Hooper SR: Health care transition for adolescents with CKD-the journey from pediatric to adult care. Adv Chronic Kidney Dis 2011;18:384-390.
27.
Sawicki GS, Lukens-Bull K, Yin X, Demars N, Huang I: Measuring the transition readiness of youth with special healthcare needs: validation of the TRAQ - Transition Readiness Assessment Questionnaire. J Pediatr Psychol 2011;36:160-171.
28.
Callahan ST, Winitzer RF, Keenan P: Transition from pediatric to adult-oriented health care: a challenge for patients with chronic disease. Curr Opin Pediatr 2001;13:310-316.
29.
Fredericks EM, Dore-Stites D, Well A, Magee JC, Freed GL, Shieck V, James Lopez M: Assessment of transition readiness skills and adherence in pediatric liver transplant recipients. Pediatr Transplant 2010;14;944-953.
30.
Cheak-Zamora NC, et al: Disparities in transition planning for youth with autism spectrum disorder. Pediatrics 2013;131:447-454.
31.
Javalkar K, Fenton N, Cohen S, Ferris M: Socioecologic factors as predictors of readiness for self-management and transition, medication adherence, and health care utilization among adolescents and young adults with chronic kidney disease. Prev Chronic Dis 2014;11:E117.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
